• Latest Posts

FDA clears T-Cell receptor natural killer cell therapy for sarcoma

Beyond Biotech podcast 35: Rare Disease Day

Syena created to deliver first-in-class TCR-NK cell therapy

Replay targets genetic brain disorders with new gene therapy company, Kaleibe

Replay receives $1.5M grant for hypoimmunogenic technology platform


New Replay HSV gene therapy company Telaria to focus on skin diseases

Replay Bio launches HSV gene therapy company to target retinal eye disease